Oct
2026
Fiera Milano, Italy
Visit us
stand 3F91, API

Orchev Pharma Pvt. Ltd.

Exhibitor at CPHI Milan 2026
About Us

Leading producer of APIs Famotidine, Ranitidine HCl and Telmisartan.

Estd. in 1989, our facility is approved by USFDA (June2025), CEP, Korean FDA, COFEPRIS Mexico, etc. helping us to meet customer need in more than 55 countries around the world.

Famotidine: We are largest manufacturer of API Famotidine (150 MT/year capacity) and it's intermediates.  For Famotidine we have approvals like CEP 2022-307, EIR-USFDA, US-DMF# 036764, China DMF Approval, Korean DMF Approval, etc.

We produce Famo intermediates ITU, IFM & FIT

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2021
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
API Producer
Fine Chemicals Company
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 3F91, API

Products Featured at CPHI Milan 2026

  • Famotidine

    Product Famotidine

    ORCHEV is the largest producer of API Famotidine (150MT/year Capacity) and having all regulatory approvals like USFDA, CEP, WHO-GMP, China DMF, ANVISA DMF filing, etc. 

    Our customer base is spread in 50+ countries including the US, Europe, Latin America, Egypt, Korea, etc.
  • Ranitidine

    Product Ranitidine

    Leading manufacturer of API - Ranitidine HCl, having approvals like USFDA, EU-GMP, CEP, Korean FDA, etc.

    Special NDMA controlled API - Ranitidine available. 
  • Telmisartan

    Product Telmisartan

    Anti Hypertension Drug.

    ORCHEV is now manufacturing Telmisartan.  With ORCHEV's belif in producing only best quality product, quality of Telmisartan produced by us excellent.


    Telmisartan Micronized : D(90) < 10 Microns